Skip to content
Colorectal Cancer Clinical Trials

Denver, Colorado

Colorectal cancer clinical trials in Denver, CO

27 colorectal cancer studies are recruiting participants at sites in Denver as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.

Call (888) 385-9581
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Denver at a glance

  • 27 studies are recruiting at a site in Denver.
  • By phase: Phase 1 (7), Phase 1/2 (8), Phase 2 (1), Phase 2/3 (1), Phase 3 (4), No phase (2), Observational (4). Studies of devices and behavioral approaches have no phase.
  • By sponsor: industry (20), university, hospital or other (6), government (1).
  • Most recent update to one of these records: November 10, 2026.

Studies recruiting in Denver

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    IDEAYA Biosciences
    Study site
    Sarah Cannon Research Institute at HealthONE
    Registry record
    NCT07503808 · updated
  2. The Vanguard Study: Testing a New Way to Screen for Cancer

    • No phase
    • Ages 45 to 75
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Kaiser Permanente-Franklin
    Registry record
    NCT06995898 · updated
  3. Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Summit Therapeutics
    Registry record
    NCT07228832 · updated
  4. Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

    • No phase
    • Ages 45 to 70
    • All sexes
    Sponsor
    NRG Oncology
    Study site
    Kaiser Permanente-Franklin
    Registry record
    NCT05080673 · updated
  5. Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    NRG Oncology
    Study sites
    Denver Health Medical Center · Kaiser Permanente-Franklin · Saint Joseph Hospital - Cancer Centers of Colorado
    Registry record
    NCT05174169 · updated
  6. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    • Observational
    • Ages 40 to 75
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    AdventHealth Porter
    Registry record
    NCT05334069 · updated
  7. Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Wake Forest University Health Sciences
    Study sites
    Colorado Blood Cancer Institute · Kaiser Permanente-Franklin · Rocky Mountain Cancer Centers-Midtown
    Registry record
    NCT06418204 · updated
  8. A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Study site
    Rocky Mountain Cancer Centers
    Registry record
    NCT06662786 · updated
  9. A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kumquat Biosciences Inc.
    Study site
    Sarah Cannon Cancer Institute at HealthONE
    Registry record
    NCT06720987 · updated
  10. A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Study site
    Rocky Mountain Cancer Centers
    Registry record
    NCT06750094 · updated
  11. A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Artios Pharma Ltd
    Study site
    Sarah Cannon Research Institute at HealthONE
    Registry record
    NCT04657068 · updated
  12. Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    ModeX Therapeutics, An OPKO Health Company
    Study site
    Sarah Cannon Research Institute
    Registry record
    NCT06239194 · updated
  13. SMP-3124LP in Adults With Advanced Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Sumitomo Pharma America, Inc.
    Study site
    Sarah Cannon Research Institute at HealthOne
    Registry record
    NCT06526819 · updated
  14. A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    BioNTech SE
    Study site
    SCRI at HCA Health One
    Registry record
    NCT07186842 · updated
  15. KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kura Oncology, Inc.
    Study site
    Sarah Cannon Research Institute at HealthONE
    Registry record
    NCT06026410 · updated
  16. Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Study sites
    Intermountain Health Cancer Center Saint Joseph · Intermountain Health Saint Joseph Hospital · Intermountain Health Saint Joseph Hospital - Research Office
    Registry record
    NCT07222800 · updated
  17. The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

    • Phase 1/2
    • Ages 12 and older
    • All sexes
    Sponsor
    PMV Pharmaceuticals, Inc
    Study site
    Rocky Mountain Cancer Center
    Registry record
    NCT04585750 · updated
  18. Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Phanes Therapeutics
    Study site
    Sarah Cannon Research Institute (SCRI)
    Registry record
    NCT05482893 · updated
  19. A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Sutro Biopharma, Inc.
    Study site
    SCRI Denver
    Registry record
    NCT07227168 · updated
  20. A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    ArriVent BioPharma, Inc.
    Study site
    Sarah Cannon Research Institute
    Registry record
    NCT07066657 · updated
  21. A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Incyte Corporation
    Study site
    Sarah Cannon Research Institue At Healthone
    Registry record
    NCT06179160 · updated
  22. A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    RasCal Therapeutics, Inc.
    Study site
    Sarah Cannon, SCRI Oncology Partners - Health One
    Registry record
    NCT04678648 · updated
  23. A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    SCRI Development Innovations, LLC
    Study site
    Rocky Mountain Cancer Center - Primary
    Registry record
    NCT07011576 · updated
  24. Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    IDEAYA Biosciences
    Study site
    SCRI - Denver
    Registry record
    NCT03947385 · updated
  25. Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer

    • Observational
    • Ages 18 to 49
    • All sexes
    Sponsor
    San Raffaele University
    Study site
    Department of Medicine-Gastroenterology, Denver Veterans Affairs Medical Center, University of Colorado Hospital
    Registry record
    NCT05732623 · updated
  26. Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Tasca Therapeutics
    Study site
    Sarah Cannon Research Institute at HealthONE
    Registry record
    NCT07030257 · updated
  27. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    • Observational
    • All ages
    • All sexes
    Sponsor
    Massive Bio, Inc.
    Study site
    Massive Bio SYNERGY-AI site
    Registry record
    NCT03452774 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Denver, CO on ClinicalTrials.gov.

Ask about studies near Denver

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Colorado

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 385-9581

or send a short form

How should we reach you?

Call